Literature DB >> 20809028

Steatosis and serum lipid patterns in patients with chronic viral hepatitis: differences related to viral etiology.

C C Vere1, Daniela Neagoe, C T Streba, Ileana Prejbeanu, G Ianoşi, Violeta Comănescu, D Pirici.   

Abstract

Lipid metabolism disorders related to viral etiology are described in chronic viral hepatitis, independent of age, gender and liver synthetic function. Steatosis is present, especially in chronic hepatitis C but also in chronic hepatitis B. Although liver biopsy is the gold standard in determining presence of steatosis, its presence can be determined by ultrasonographic examination as an initial screening test. Our aim in this study was to evaluate the presence of steatosis in chronic hepatitis B and C, to determine its frequency in both hepatitis type, and to explore possible relationships between presence of steatosis, lipid metabolism disorders and viral etiology. Our study lot included 66 patients, 36 subjects with chronic hepatitis C, and 30 with chronic hepatitis B. We only encountered significant levels of steatosis in the chronic hepatitis B sub-group. We found the average age, cholesterol, triglyceride, HDL-C, VLDL-C levels in the group with steatosis to be significantly higher than those in the group without steatosis (p < 0.05). Ultrasound reports of hepatic steatosis were particularly associated with histological inflammation, as well as fibrosis; however, the sensitivity and specificity of steatosis on ultrasound was poor when compared to steatosis on biopsy. Hepatic steatosis was significantly more frequent in chronic hepatitis C than in chronic hepatitis B. Severe inflammation and advanced fibrosis were more frequently found in HCV-infected patients with steatosis than in patients without steatosis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20809028

Source DB:  PubMed          Journal:  Rom J Morphol Embryol        ISSN: 1220-0522            Impact factor:   1.033


  6 in total

1.  Global hepatitis C elimination: history, evolution, revolutionary changes and barriers to overcome.

Authors:  Carmen Nicoleta Oancea; Anca Elena Butaru; Costin Teodor Streba; Daniel Pirici; Ion Rogoveanu; Mihai Mircea Diculescu; Dan Ionuţ Gheonea
Journal:  Rom J Morphol Embryol       Date:  2020 Jul-Sep       Impact factor: 1.033

2.  Fish oil increases atherosclerosis and hepatic steatosis, although decreases serum cholesterol in Wistar rat.

Authors:  Minoo M-Shirazi; Fourugh-Azam Taleban; Ali Reza Abadi; Masoumeh Sabetkasaei
Journal:  J Res Med Sci       Date:  2011-05       Impact factor: 1.852

3.  Serum lipid profile as a marker of liver impairment in hepatitis B Cirrhosis patients.

Authors:  Sadia Qamar Arain; Farah Naz Talpur; Naseem Aslam Channa; Muhammad Shahbaz Ali; Hassan Imran Afridi
Journal:  Lipids Health Dis       Date:  2017-03-01       Impact factor: 3.876

4.  Resource Management through Artificial Intelligence in Screening Programs-Key for the Successful Elimination of Hepatitis C.

Authors:  Anca Elena Butaru; Mădălin Mămuleanu; Costin Teodor Streba; Irina Paula Doica; Mihai Mircea Diculescu; Dan Ionuț Gheonea; Carmen Nicoleta Oancea
Journal:  Diagnostics (Basel)       Date:  2022-01-29

5.  E-cadherin and aquaporin 1 co-expression analysis in hepatocellular carcinoma: a pilot study.

Authors:  Ana Maria Ciurea; Cristin Constantin Vere; Cristiana Gabriela Popp; Costin Teodor Streba; Mihaela Caliţa; Daniel Pirici; Liliana Cercelaru; Michael Schenker; Dan Ionuţ Gheonea; Ionica Pirici
Journal:  Rom J Morphol Embryol       Date:  2021 Apr-Jun       Impact factor: 1.033

6.  MR spectroscopy of the liver - a reliable non-invasive alternative for evaluating non-alcoholic fatty liver disease.

Authors:  Alina Maria Lăpădat; Lucian Mihai Florescu; Nicolae Cătălin Manea; Dan Ionuţ Gheonea; Daniel Pirici; Diana Rodica Tudoraşcu; Răzvan Ene; Ioana Andreea Gheonea
Journal:  Rom J Morphol Embryol       Date:  2020       Impact factor: 1.033

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.